Angiochem Appoints Executive Chairman and Elects New Board of Directors
MONTREAL, QC--(Marketwired - April 28, 2016) - Angiochem, a biotechnology company developing peptide drug conjugates uniquely capable of crossing the blood-brain barrier, has appointed Mr. John Huss as Executive Chairman and elected a new board of …